Back to 2025 Posters
EARLY AND INTRAOPERATIVE OUTCOMES OF REDO ENDOSCOPIC SLEEVE GASTROPLASTY: IS IT FEASIBLE?
Cesar D. Quiroz Guadarrama
*2, Felipe Giron
1, martin edgardo rojano rodriguez
2, Gontrand lopez nava
3, Natan Zundel
41General Surgery, Fundacion Santa Fe de Bogota, Bogota, Colombia; 2Clinical del Noroeste, Hermosillo, Sonora, Mexico; 3Hospital de Sanchinarro, Madrid, Madrid, Spain; 4Florida International University, Miami, FL
Introduction:
Obesity and weight regain following initial weight-loss interventions remain significant challenges in bariatric care. Endoscopic Sleeve Gastroplasty (ESG) has emerged as a minimally invasive alternative for primary and revisional bariatric procedures, offering favorable safety and efficacy profiles. However, limited data exist on the feasibility and outcomes of Redo ESG procedures. This study aims to evaluate the safety, procedural details, and early outcomes of Redo ESG in patients seeking revisional endoscopic weight-loss options.
Objective:
To describe safety, clinical experience, and early intraoperative outcomes of Redo Endoscopic Sleeve Gastroplasty (ESG) in a high-volume bariatric center in 2024.
Methods:
A retrospective observational study was conducted using a prospectively obtained database. The study included all patients who underwent Redo ESG between January and December 2024. Data collected included baseline demographics, intraoperative findings, and postoperative outcomes. Variables analyzed comprised operative time, procedural details, complications, and endoscopic findings. Statistical analyses were performed as appropriate to variable Nature.
Results:
48 patients underwent Redo ESG. Mean age was 39.5 ± 8.06 years. 32 were females and 16 males, with a mean preoperative body mass index (BMI) of 34.66 ± 6.72 kg/m2. All patients desired a revisional endoscopic option. Mean operative time was 30.88 ± 7,78 minutes. Only 1 intraoperative complications was presented (bleeding requiring adrenaline injection 2.08%). 11 patients presented postoperative pain with a mean value in the analogue scale of 3, 4,2 % presented nausea and vomiting. No reinterventions were required, and the mean hospital stay was 5.54 hours. No other early complications were observed.
Conclusion:
Redo Endoscopic Sleeve Gastroplasty appears to be a feasible and safe revisional option in a high-volume bariatric center, demonstrating favorable intraoperative and early postoperative outcomes. With minimal complications, low pain scores, and short hospital stays, this procedure offers a promising alternative for patients with weight regain or suboptimal results from previous interventions. Further studies with long-term follow-up are needed to assess sustained efficacy and overall patient satisfaction.
Back to 2025 Posters
